MS Australia has awarded over $3 million in grants for multiple sclerosis (MS) research, providing a major boost in the fight against this increasing and accelerating disease.
The number of Australians living with multiple sclerosis (MS) is increasing at a significant and accelerating rate.
MS Australia congratulates Dr Therese Burke who has been honoured for her significant service to medicine, particularly multiple sclerosis research, and to nursing, by being made a Member of the Order of Australia (AM) in today’s 2023 Australia Day Honours List.
As well as depleting immune cells, new research shows cladribine (Mavenclad) may impede their movement into brain tissue, preventing further damage by multiple sclerosis.
MS Australia CEO Rohan Greenland answers the question, ‘what are the big breakthroughs that lie ahead?’ He details the latest research, treatments and programs that will propel us faster and further along the ‘pathways to cures’. Â
Many people living with multiple sclerosis modify their dietary intake after their MS diagnosis, but there is little evidence that dietary modifications influence MS outcomes. A recent Australian study has explored the impact of diet quality specifically on three common MS symptoms; depression, anxiety and fatigue.
The MS Australia Clinical Trials Network is a central point of information for people interested in participating in clinical trials and research studies in MS, or in finding out more details of studies in MS.
MS Plus employee Ben Holgate says he wants to give something back to the charity where he’s worked for the past five years.
MS Australia will be making a submission advocating for the subcutaneous form of Tysabri® to be listed on the PBS, as we welcome affordable access to all treatment options that have been shown in clinical trials to provide safe and effective treatment for MS.
